Cargando…
Advances in Molecular Mechanisms and Treatment of Radiation-Induced Pulmonary Fibrosis
Radiation-induced pulmonary fibrosis (RIPF) is a common complication in patients with lung cancer and breast cancer after receiving thoracic radiotherapy. The average incidence of RIPF is 16%-28% after radiotherapy. RIPF includes a heterogeneous group of lung disorders characterized by progressive a...
Autores principales: | Chen, Zhongjie, Wu, Zhiqiang, Ning, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197541/ https://www.ncbi.nlm.nih.gov/pubmed/30342294 http://dx.doi.org/10.1016/j.tranon.2018.09.009 |
Ejemplares similares
-
Molecular Mechanisms and Treatment of Radiation-Induced Lung Fibrosis
por: Ding, Nian-Hua, et al.
Publicado: (2013) -
Molecular and cellular mechanisms of pulmonary fibrosis
por: Todd, Nevins W, et al.
Publicado: (2012) -
The Role of Nrf2 in Pulmonary Fibrosis: Molecular Mechanisms and Treatment Approaches
por: Wang, Yu, et al.
Publicado: (2022) -
Cellular and Molecular Mechanisms in Idiopathic Pulmonary Fibrosis
por: Zhang, Yihang, et al.
Publicado: (2023) -
Mesenchymal Stem Cells in Radiation-Induced Pulmonary Fibrosis: Future Prospects
por: Chen, Yusha, et al.
Publicado: (2022)